Latest News & Features
Big Pharma
The special 25th anniversary BIO-Europe 2019 global life science partnering event will be held November 11–13, 2019, in Hamburg, Germany. 22 October 2019
Americas
The Annual Summit on Life Sciences IP Due Diligence to be held on November 14 and 15 in Boston, MA, is a one-of-a-kind, interactive forum where diligence experts discuss best practices and strategies for executing a proper IP due diligence analysis for incumbent portfolios and those of potential targets. 22 October 2019
Americas
A joint venture between gene-editing startup CRISPR Therapeutics and German pharmaceutical company Bayer will come under the control of CRISPR Therapeutics, according to the pair’s proposed plans. 22 October 2019
Americas
While the next Alice or Mayo is unlikely to be handed down next year, there are many slightly less “revolutionary" developments likely to crop up in 2020, according to Charles Larsen, partner at White & Case. 22 October 2019
Big Pharma
The US House Committee on Energy & Commerce has voted to advance a drug pricing plan which would lower the cost of many prescription drugs. 21 October 2019
Americas
The US Food and Drug Administration has announced record approvals of generic drugs in 2019, amid growing pressure over drug prices in the US. 21 October 2019
Americas
Tensions between public use, drug laws and regulators make IP around Cannabis a complex situation, explains Ludmila Kawakami and Ana Paula D. C. Couto of Di Blasi, Parente & Associados. 21 October 2019
Big Pharma
Pfizer UK has launched a new social media campaign urging people not to be “catfished” into buying counterfeit drugs. 17 October 2019
Big Pharma
Alexion Pharmaceuticals is to acquire immune-system specialist Achillion for almost $1 billion dollars. 17 October 2019
Big Pharma
Brexit uncertainty is already having a negative impact on UK science, according to The Royal Society, the UK’s national academy of sciences. 17 October 2019